Home LiteratureArticle Details
PMID: 2468550 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Growth factor control of myoepithelial-cell differentiation in cultures of human mammary gland.

Differentiation; research in biological diversity ·Vol. 39 ·No. 3 ·1988-12-00 ·Pages 197-215

Petersen OW, van Deurs B

Abstract

The relationship between growth and cytodifferentiation was studied in cultured human mammary myoepithelial cells under serum-free culture conditions. Myoepithelial-cell differentiation was monitored by quantifying cells showing immunoreactivity to the muscle isoform of actin; to the membrane glycoprotein common acute lymphoblastic leukemia antigen (CALLA); and to type IV collagen. Growth was quantified either by measuring the actual increase in cell number, or in a more-sensitive assay using immunoreactivity to the cell-proliferation-associated nuclear antigen Ki-67 as a measurement of the number of cells leaving the G0-phase of the cell cycle. The results showed that: (a) Primary cultures of myoepithelial cells on DME-F12 supplemented with cholera toxin (CT) alone resulted in the formation of quiescent cell islets (in the G0-phase of the cell cycle) showing phenotypic traits preserved from the in vivo situation (actin- and CALLA-positive cells with little or no type-IV-collagen immunoreactivity). (b) After addition of epidermal growth factor (EGF), with an ED50 of 1-10 ng/ml, in the presence of CT, the cells entered the G1-phase of the cell cycle, without further increase in cell number. At the same ED50 of EGF, the frequency of CALLA-positive cells decreased, while the number of cells immunoreactive for type IV collagen increased with a maximal effect of EGF seen after 7-11 days. During the same period, the cells remained fully differentiated with respect to actin immunoreactivity. (c) Further addition of insulin (I) to the medium in the presence of EGF and CT resulted in the cells entering an exponential growth phase associated with simultaneous decrease in actin immunoreactivity with a maximal effect of I after 11 days of exposure. The dose-response curve to I was virtually identical for stimulating cell proliferation and for reducing the frequency of actin-immunoreactive cells (ED50 in the range of 30 ng/ml), suggesting that the two processes were controlled by the same initial I-receptor interaction. (d) Some reduction in the number of actin-positive cells was exerted by I-EGF-CT independently of the mitogenic response, but this reduction was further augmented if the cells were allowed to proliferate. (e) Time-course studies of quiescent (G0-phase) cells stimulated to exponential growth revealed that entrance of cells into the G1-phase of the cell cycle preceded the loss of muscle actin filaments. (f) Exponentially growing actin-negative epithelial cells did not resume a myoepithelial phenotype in density-arrested postconfluent cultures.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Animals Antibodies Antibodies, Monoclonal Antigens, Differentiation/analysis Antigens, Neoplasm/analysis Cell Differentiation/drug effects Cell Division/drug effects Cells, Cultured Cholera Toxin/pharmacology Epidermal Growth Factor/pharmacology Epithelial Cells Epithelium/drug effects Epitopes/analysis Female Growth Substances/pharmacology Humans Insulin/pharmacology Keratins/analysis Mammary Glands, Animal/cytology,drug effects Muscles/cytology,drug effects Neprilysin Receptors, Estrogen/analysis
Chemicals
Antibodies Antibodies, Monoclonal Antigens, Differentiation Antigens, Neoplasm Epitopes Growth Substances Insulin Receptors, Estrogen Epidermal Growth Factor Keratins Cholera Toxin Neprilysin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Petersen O W
Department of Anatomy, Panum Institute, University of Copenhagen, Denmark.
van Deurs B
Article Info
Journal
Differentiation; research in biological diversity
Abbr.
Differentiation
ISSN
0301-4681
Published
1988-12-00
Pages
197-215
Language
English
Region
England
NLM ID
0401650
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]